FDA inspection
Apotex Research Private Limited: FDA inspection ending May 8, 2026
FDA inspection 1320456 · No Action Indicated (NAI) · Bangalore
Key facts
| Inspection ID | 1320456 |
|---|---|
| Firm | Apotex Research Private Limited |
| FEI number | 3007078919 |
| Address | Bioequivalence Centre, Site No. 1 & 2, Bommasandra Industrial Area, 4th Phase, Jigani Link Road |
| City | Bangalore |
| Country | India |
| Fiscal year | 2026 |
| Inspection end date | May 8, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data